Bringing you the Best Analytical Legal News
The proceeds of the QIP are proposed to be utilized towards re-payment and /or prepayment of certain outstanding borrowings of the Company and certain of its subsidiaries, and general corporate purposes.
Shardul Amarchand Mangaldas Advises Krishna Institute of Medical Sciences Ltd. on its ₹1,500 Crore Qualified Institutions Placement
The QIP comprised participation from a diverse set of institutional investors, including the International Finance Corporation (IFC), as well as leading mutual funds and insurance companies such as HSBC Mutual Fund, Edelweiss Mutual Fund, Axis Mutual Fund, ICICI Prudential Life Insurance, HDFC Life Insurance and Kotak Mahindra Life Insurance.